Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Immuno-oncology Drugs Market 2018, Forecast to 2023
Scope of the Report:
This report focuses on the Immuno-oncology Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Immuno-oncology Drugs is expected to grow at a CAGR of roughly 14.2% over the next five years, will reach 109200 million US$ in 2023, from 49200 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Chapter 1, to describe Immuno-oncology Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Immuno-oncology Drugs, with sales, revenue, and price of Immuno-oncology Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Immuno-oncology Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Immuno-oncology Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Immuno-oncology Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
This report focuses on the Immuno-oncology Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Immuno-oncology Drugs is expected to grow at a CAGR of roughly 14.2% over the next five years, will reach 109200 million US$ in 2023, from 49200 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Amgen, Inc
- AstraZeneca, Plc
- Bristol-Myers Squibb
- Celgene Corporation
- Eli Lilly and Company
- Merck & Co.
- Hoffmann-La Roche AG
- Johnson & Johnson
- Novartis International AG
- AbbVie, Inc.
- Pfizer Inc.
- Sanofi S.A.
- EMD Serono, Inc.
- Gilead Sciences Inc.
- Prometheus Therapeutics & Diagnostics
- Aduro BioTech
- Galena Biopharma
- Bavarian Nordic
- Celldex Therapeutics
- ImmunoCellular Therapeutics
- Incyte
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Immune Checkpoint Inhibitors
- Monoclonal Antibodies
- Cytokine-Based Immunotherapy
- Cancer Vaccines
- CAR-T Cell Therapy
- Hospitals
- Pharmacies
- Online Pharmacies
Chapter 1, to describe Immuno-oncology Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Immuno-oncology Drugs, with sales, revenue, and price of Immuno-oncology Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Immuno-oncology Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Immuno-oncology Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Immuno-oncology Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 MARKET OVERVIEW
1.1 Immuno-oncology Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Immune Checkpoint Inhibitors
1.2.2 Monoclonal Antibodies
1.2.3 Cytokine-Based Immunotherapy
1.2.4 Cancer Vaccines
1.2.5 CAR-T Cell Therapy
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Pharmacies
1.3.3 Online Pharmacies
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Amgen, Inc
2.1.1 Business Overview
2.1.1.1 Amgen, Inc Description
2.1.1.2 Amgen, Inc Headquarter, Main Business and Finance Overview
2.1.2 Amgen, Inc Immuno-oncology Drugs Product Introduction
2.1.2.1 Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
2.1.2.2 Immuno-oncology Drugs Product Information
2.1.3 Amgen, Inc Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Amgen, Inc Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Amgen, Inc Immuno-oncology Drugs Market Share in 2017
2.2 AstraZeneca, Plc
2.2.1 Business Overview
2.2.1.1 AstraZeneca, Plc Description
2.2.1.2 AstraZeneca, Plc Headquarter, Main Business and Finance Overview
2.2.2 AstraZeneca, Plc Immuno-oncology Drugs Product Introduction
2.2.2.1 Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
2.2.2.2 Immuno-oncology Drugs Product Information
2.2.3 AstraZeneca, Plc Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 AstraZeneca, Plc Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global AstraZeneca, Plc Immuno-oncology Drugs Market Share in 2017
2.3 Bristol-Myers Squibb
2.3.1 Business Overview
2.3.1.1 Bristol-Myers Squibb Description
2.3.1.2 Bristol-Myers Squibb Headquarter, Main Business and Finance Overview
2.3.2 Bristol-Myers Squibb Immuno-oncology Drugs Product Introduction
2.3.2.1 Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
2.3.2.2 Immuno-oncology Drugs Product Information
2.3.3 Bristol-Myers Squibb Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Bristol-Myers Squibb Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Bristol-Myers Squibb Immuno-oncology Drugs Market Share in 2017
2.4 Celgene Corporation
2.4.1 Business Overview
2.4.1.1 Celgene Corporation Description
2.4.1.2 Celgene Corporation Headquarter, Main Business and Finance Overview
2.4.2 Celgene Corporation Immuno-oncology Drugs Product Introduction
2.4.2.1 Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
2.4.2.2 Immuno-oncology Drugs Product Information
2.4.3 Celgene Corporation Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Celgene Corporation Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Celgene Corporation Immuno-oncology Drugs Market Share in 2017
2.5 Eli Lilly and Company
2.5.1 Business Overview
2.5.1.1 Eli Lilly and Company Description
2.5.1.2 Eli Lilly and Company Headquarter, Main Business and Finance Overview
2.5.2 Eli Lilly and Company Immuno-oncology Drugs Product Introduction
2.5.2.1 Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
2.5.2.2 Immuno-oncology Drugs Product Information
2.5.3 Eli Lilly and Company Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Eli Lilly and Company Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Eli Lilly and Company Immuno-oncology Drugs Market Share in 2017
2.6 Merck & Co.
2.6.1 Business Overview
2.6.1.1 Merck & Co. Description
2.6.1.2 Merck & Co. Headquarter, Main Business and Finance Overview
2.6.2 Merck & Co. Immuno-oncology Drugs Product Introduction
2.6.2.1 Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
2.6.2.2 Immuno-oncology Drugs Product Information
2.6.3 Merck & Co. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Merck & Co. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Merck & Co. Immuno-oncology Drugs Market Share in 2017
2.7 Hoffmann-La Roche AG
2.7.1 Business Overview
2.7.1.1 Hoffmann-La Roche AG Description
2.7.1.2 Hoffmann-La Roche AG Headquarter, Main Business and Finance Overview
2.7.2 Hoffmann-La Roche AG Immuno-oncology Drugs Product Introduction
2.7.2.1 Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
2.7.2.2 Immuno-oncology Drugs Product Information
2.7.3 Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Hoffmann-La Roche AG Immuno-oncology Drugs Market Share in 2017
2.8 Johnson & Johnson
2.8.1 Business Overview
2.8.1.1 Johnson & Johnson Description
2.8.1.2 Johnson & Johnson Headquarter, Main Business and Finance Overview
2.8.2 Johnson & Johnson Immuno-oncology Drugs Product Introduction
2.8.2.1 Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
2.8.2.2 Immuno-oncology Drugs Product Information
2.8.3 Johnson & Johnson Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Johnson & Johnson Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Johnson & Johnson Immuno-oncology Drugs Market Share in 2017
2.9 Novartis International AG
2.9.1 Business Overview
2.9.1.1 Novartis International AG Description
2.9.1.2 Novartis International AG Headquarter, Main Business and Finance Overview
2.9.2 Novartis International AG Immuno-oncology Drugs Product Introduction
2.9.2.1 Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
2.9.2.2 Immuno-oncology Drugs Product Information
2.9.3 Novartis International AG Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Novartis International AG Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Novartis International AG Immuno-oncology Drugs Market Share in 2017
2.10 AbbVie, Inc.
2.10.1 Business Overview
2.10.1.1 AbbVie, Inc. Description
2.10.1.2 AbbVie, Inc. Headquarter, Main Business and Finance Overview
2.10.2 AbbVie, Inc. Immuno-oncology Drugs Product Introduction
2.10.2.1 Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
2.10.2.2 Immuno-oncology Drugs Product Information
2.10.3 AbbVie, Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 AbbVie, Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global AbbVie, Inc. Immuno-oncology Drugs Market Share in 2017
2.11 Pfizer Inc.
2.11.1 Business Overview
2.11.2 Pfizer Inc. Immuno-oncology Drugs Product Introduction
2.11.3 Pfizer Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Sanofi S.A.
2.12.1 Business Overview
2.12.2 Sanofi S.A. Immuno-oncology Drugs Product Introduction
2.12.3 Sanofi S.A. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 EMD Serono, Inc.
2.13.1 Business Overview
2.13.2 EMD Serono, Inc. Immuno-oncology Drugs Product Introduction
2.13.3 EMD Serono, Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Gilead Sciences Inc.
2.14.1 Business Overview
2.14.2 Gilead Sciences Inc. Immuno-oncology Drugs Product Introduction
2.14.3 Gilead Sciences Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Prometheus Therapeutics & Diagnostics
2.15.1 Business Overview
2.15.2 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Product Introduction
2.15.3 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Aduro BioTech
2.16.1 Business Overview
2.16.2 Aduro BioTech Immuno-oncology Drugs Product Introduction
2.16.3 Aduro BioTech Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Galena Biopharma
2.17.1 Business Overview
2.17.2 Galena Biopharma Immuno-oncology Drugs Product Introduction
2.17.3 Galena Biopharma Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Bavarian Nordic
2.18.1 Business Overview
2.18.2 Bavarian Nordic Immuno-oncology Drugs Product Introduction
2.18.3 Bavarian Nordic Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Celldex Therapeutics
2.19.1 Business Overview
2.19.2 Celldex Therapeutics Immuno-oncology Drugs Product Introduction
2.19.3 Celldex Therapeutics Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 ImmunoCellular Therapeutics
2.20.1 Business Overview
2.20.2 ImmunoCellular Therapeutics Immuno-oncology Drugs Product Introduction
2.20.3 ImmunoCellular Therapeutics Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21 Incyte
2.21.1 Business Overview
2.21.2 Incyte Immuno-oncology Drugs Product Introduction
2.21.3 Incyte Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL IMMUNO-ONCOLOGY DRUGS MARKET COMPETITION, BY MANUFACTURER
3.1 Global Immuno-oncology Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Immuno-oncology Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Immuno-oncology Drugs Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Immuno-oncology Drugs Manufacturer Market Share in 2017
3.4.2 Top 5 Immuno-oncology Drugs Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 GLOBAL IMMUNO-ONCOLOGY DRUGS MARKET ANALYSIS BY REGIONS
4.1 Global Immuno-oncology Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Immuno-oncology Drugs Sales by Regions (2013-2018)
4.1.2 Global Immuno-oncology Drugs Revenue by Regions (2013-2018)
4.2 North America Immuno-oncology Drugs Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Immuno-oncology Drugs Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Immuno-oncology Drugs Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Immuno-oncology Drugs Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Immuno-oncology Drugs Sales, Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA IMMUNO-ONCOLOGY DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
5.1 North America Immuno-oncology Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Immuno-oncology Drugs Sales by Countries (2013-2018)
5.1.2 North America Immuno-oncology Drugs Revenue by Countries (2013-2018)
5.1.3 United States Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
5.1.4 Canada Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
5.1.5 Mexico Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
5.2 North America Immuno-oncology Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Immuno-oncology Drugs Sales by Manufacturers (2016-2017)
5.2.2 North America Immuno-oncology Drugs Revenue by Manufacturers (2016-2017)
5.3 North America Immuno-oncology Drugs Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Immuno-oncology Drugs Sales and Sales Share by Type (2013-2018)
5.3.2 North America Immuno-oncology Drugs Revenue and Revenue Share by Type (2013-2018)
5.4 North America Immuno-oncology Drugs Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Immuno-oncology Drugs Sales and Sales Share by Application (2013-2018)
5.4.2 North America Immuno-oncology Drugs Revenue and Revenue Share by Application (2013-2018)
6 EUROPE IMMUNO-ONCOLOGY DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
6.1 Europe Immuno-oncology Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Immuno-oncology Drugs Sales by Countries (2013-2018)
6.1.2 Europe Immuno-oncology Drugs Revenue by Countries (2013-2018)
6.1.3 Germany Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
6.1.4 UK Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
6.1.5 France Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
6.1.6 Russia Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
6.1.7 Italy Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
6.2 Europe Immuno-oncology Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Immuno-oncology Drugs Sales by Manufacturers (2016-2017)
6.2.2 Europe Immuno-oncology Drugs Revenue by Manufacturers (2016-2017)
6.3 Europe Immuno-oncology Drugs Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Immuno-oncology Drugs Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Immuno-oncology Drugs Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Immuno-oncology Drugs Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Immuno-oncology Drugs Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Immuno-oncology Drugs Revenue and Revenue Share by Application (2013-2018)
7 ASIA-PACIFIC IMMUNO-ONCOLOGY DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
7.1 Asia-Pacific Immuno-oncology Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Immuno-oncology Drugs Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Immuno-oncology Drugs Revenue by Countries (2013-2018)
7.1.3 China Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
7.1.4 Japan Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
7.1.5 Korea Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
7.1.6 India Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Immuno-oncology Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Immuno-oncology Drugs Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Immuno-oncology Drugs Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Immuno-oncology Drugs Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Immuno-oncology Drugs Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Immuno-oncology Drugs Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Immuno-oncology Drugs Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Immuno-oncology Drugs Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Immuno-oncology Drugs Revenue and Revenue Share by Application (2013-2018)
8 SOUTH AMERICA IMMUNO-ONCOLOGY DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
8.1 South America Immuno-oncology Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Immuno-oncology Drugs Sales by Countries (2013-2018)
8.1.2 South America Immuno-oncology Drugs Revenue by Countries (2013-2018)
8.1.3 Brazil Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
8.1.4 Argentina Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
8.1.5 Colombia Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
8.2 South America Immuno-oncology Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Immuno-oncology Drugs Sales by Manufacturers (2016-2017)
8.2.2 South America Immuno-oncology Drugs Revenue by Manufacturers (2016-2017)
8.3 South America Immuno-oncology Drugs Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Immuno-oncology Drugs Sales and Sales Share by Type (2013-2018)
8.3.2 South America Immuno-oncology Drugs Revenue and Revenue Share by Type (2013-2018)
8.4 South America Immuno-oncology Drugs Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Immuno-oncology Drugs Sales and Sales Share by Application (2013-2018)
8.4.2 South America Immuno-oncology Drugs Revenue and Revenue Share by Application (2013-2018)
9 MIDDLE EAST AND AFRICA IMMUNO-ONCOLOGY DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
9.1 Middle East and Africa Immuno-oncology Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Immuno-oncology Drugs Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Immuno-oncology Drugs Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
9.1.4 UAE Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
9.1.5 Egypt Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
9.1.7 South Africa Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Immuno-oncology Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Immuno-oncology Drugs Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Immuno-oncology Drugs Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Immuno-oncology Drugs Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Immuno-oncology Drugs Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Immuno-oncology Drugs Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Immuno-oncology Drugs Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Immuno-oncology Drugs Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Immuno-oncology Drugs Revenue and Revenue Share by Application (2013-2018)
10 GLOBAL IMMUNO-ONCOLOGY DRUGS MARKET SEGMENT BY TYPE
10.1 Global Immuno-oncology Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Immuno-oncology Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Immuno-oncology Drugs Revenue and Market Share by Type (2013-2018)
10.2 Immune Checkpoint Inhibitors Sales Growth and Price
10.2.1 Global Immune Checkpoint Inhibitors Sales Growth (2013-2018)
10.2.2 Global Immune Checkpoint Inhibitors Price (2013-2018)
10.3 Monoclonal Antibodies Sales Growth and Price
10.3.1 Global Monoclonal Antibodies Sales Growth (2013-2018)
10.3.2 Global Monoclonal Antibodies Price (2013-2018)
10.4 Cytokine-Based Immunotherapy Sales Growth and Price
10.4.1 Global Cytokine-Based Immunotherapy Sales Growth (2013-2018)
10.4.2 Global Cytokine-Based Immunotherapy Price (2013-2018)
10.5 Cancer Vaccines Sales Growth and Price
10.5.1 Global Cancer Vaccines Sales Growth (2013-2018)
10.5.2 Global Cancer Vaccines Price (2013-2018)
10.6 CAR-T Cell Therapy Sales Growth and Price
10.6.1 Global CAR-T Cell Therapy Sales Growth (2013-2018)
10.6.2 Global CAR-T Cell Therapy Price (2013-2018)
11 GLOBAL IMMUNO-ONCOLOGY DRUGS MARKET SEGMENT BY APPLICATION
11.1 Global Immuno-oncology Drugs Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Pharmacies Sales Growth (2013-2018)
11.4 Online Pharmacies Sales Growth (2013-2018)
12 IMMUNO-ONCOLOGY DRUGS MARKET FORECAST (2018-2023)
12.1 Global Immuno-oncology Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Immuno-oncology Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Immuno-oncology Drugs Market Forecast (2018-2023)
12.2.2 Europe Immuno-oncology Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Immuno-oncology Drugs Market Forecast (2018-2023)
12.2.4 South America Immuno-oncology Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Immuno-oncology Drugs Market Forecast (2018-2023)
12.3 Immuno-oncology Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Immuno-oncology Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Immuno-oncology Drugs Market Share Forecast by Type (2018-2023)
12.4 Immuno-oncology Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Immuno-oncology Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Immuno-oncology Drugs Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
1.1 Immuno-oncology Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Immune Checkpoint Inhibitors
1.2.2 Monoclonal Antibodies
1.2.3 Cytokine-Based Immunotherapy
1.2.4 Cancer Vaccines
1.2.5 CAR-T Cell Therapy
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Pharmacies
1.3.3 Online Pharmacies
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Amgen, Inc
2.1.1 Business Overview
2.1.1.1 Amgen, Inc Description
2.1.1.2 Amgen, Inc Headquarter, Main Business and Finance Overview
2.1.2 Amgen, Inc Immuno-oncology Drugs Product Introduction
2.1.2.1 Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
2.1.2.2 Immuno-oncology Drugs Product Information
2.1.3 Amgen, Inc Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Amgen, Inc Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Amgen, Inc Immuno-oncology Drugs Market Share in 2017
2.2 AstraZeneca, Plc
2.2.1 Business Overview
2.2.1.1 AstraZeneca, Plc Description
2.2.1.2 AstraZeneca, Plc Headquarter, Main Business and Finance Overview
2.2.2 AstraZeneca, Plc Immuno-oncology Drugs Product Introduction
2.2.2.1 Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
2.2.2.2 Immuno-oncology Drugs Product Information
2.2.3 AstraZeneca, Plc Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 AstraZeneca, Plc Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global AstraZeneca, Plc Immuno-oncology Drugs Market Share in 2017
2.3 Bristol-Myers Squibb
2.3.1 Business Overview
2.3.1.1 Bristol-Myers Squibb Description
2.3.1.2 Bristol-Myers Squibb Headquarter, Main Business and Finance Overview
2.3.2 Bristol-Myers Squibb Immuno-oncology Drugs Product Introduction
2.3.2.1 Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
2.3.2.2 Immuno-oncology Drugs Product Information
2.3.3 Bristol-Myers Squibb Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Bristol-Myers Squibb Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Bristol-Myers Squibb Immuno-oncology Drugs Market Share in 2017
2.4 Celgene Corporation
2.4.1 Business Overview
2.4.1.1 Celgene Corporation Description
2.4.1.2 Celgene Corporation Headquarter, Main Business and Finance Overview
2.4.2 Celgene Corporation Immuno-oncology Drugs Product Introduction
2.4.2.1 Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
2.4.2.2 Immuno-oncology Drugs Product Information
2.4.3 Celgene Corporation Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Celgene Corporation Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Celgene Corporation Immuno-oncology Drugs Market Share in 2017
2.5 Eli Lilly and Company
2.5.1 Business Overview
2.5.1.1 Eli Lilly and Company Description
2.5.1.2 Eli Lilly and Company Headquarter, Main Business and Finance Overview
2.5.2 Eli Lilly and Company Immuno-oncology Drugs Product Introduction
2.5.2.1 Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
2.5.2.2 Immuno-oncology Drugs Product Information
2.5.3 Eli Lilly and Company Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Eli Lilly and Company Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Eli Lilly and Company Immuno-oncology Drugs Market Share in 2017
2.6 Merck & Co.
2.6.1 Business Overview
2.6.1.1 Merck & Co. Description
2.6.1.2 Merck & Co. Headquarter, Main Business and Finance Overview
2.6.2 Merck & Co. Immuno-oncology Drugs Product Introduction
2.6.2.1 Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
2.6.2.2 Immuno-oncology Drugs Product Information
2.6.3 Merck & Co. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Merck & Co. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Merck & Co. Immuno-oncology Drugs Market Share in 2017
2.7 Hoffmann-La Roche AG
2.7.1 Business Overview
2.7.1.1 Hoffmann-La Roche AG Description
2.7.1.2 Hoffmann-La Roche AG Headquarter, Main Business and Finance Overview
2.7.2 Hoffmann-La Roche AG Immuno-oncology Drugs Product Introduction
2.7.2.1 Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
2.7.2.2 Immuno-oncology Drugs Product Information
2.7.3 Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Hoffmann-La Roche AG Immuno-oncology Drugs Market Share in 2017
2.8 Johnson & Johnson
2.8.1 Business Overview
2.8.1.1 Johnson & Johnson Description
2.8.1.2 Johnson & Johnson Headquarter, Main Business and Finance Overview
2.8.2 Johnson & Johnson Immuno-oncology Drugs Product Introduction
2.8.2.1 Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
2.8.2.2 Immuno-oncology Drugs Product Information
2.8.3 Johnson & Johnson Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Johnson & Johnson Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Johnson & Johnson Immuno-oncology Drugs Market Share in 2017
2.9 Novartis International AG
2.9.1 Business Overview
2.9.1.1 Novartis International AG Description
2.9.1.2 Novartis International AG Headquarter, Main Business and Finance Overview
2.9.2 Novartis International AG Immuno-oncology Drugs Product Introduction
2.9.2.1 Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
2.9.2.2 Immuno-oncology Drugs Product Information
2.9.3 Novartis International AG Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Novartis International AG Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Novartis International AG Immuno-oncology Drugs Market Share in 2017
2.10 AbbVie, Inc.
2.10.1 Business Overview
2.10.1.1 AbbVie, Inc. Description
2.10.1.2 AbbVie, Inc. Headquarter, Main Business and Finance Overview
2.10.2 AbbVie, Inc. Immuno-oncology Drugs Product Introduction
2.10.2.1 Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
2.10.2.2 Immuno-oncology Drugs Product Information
2.10.3 AbbVie, Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 AbbVie, Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global AbbVie, Inc. Immuno-oncology Drugs Market Share in 2017
2.11 Pfizer Inc.
2.11.1 Business Overview
2.11.2 Pfizer Inc. Immuno-oncology Drugs Product Introduction
2.11.3 Pfizer Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Sanofi S.A.
2.12.1 Business Overview
2.12.2 Sanofi S.A. Immuno-oncology Drugs Product Introduction
2.12.3 Sanofi S.A. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 EMD Serono, Inc.
2.13.1 Business Overview
2.13.2 EMD Serono, Inc. Immuno-oncology Drugs Product Introduction
2.13.3 EMD Serono, Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Gilead Sciences Inc.
2.14.1 Business Overview
2.14.2 Gilead Sciences Inc. Immuno-oncology Drugs Product Introduction
2.14.3 Gilead Sciences Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Prometheus Therapeutics & Diagnostics
2.15.1 Business Overview
2.15.2 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Product Introduction
2.15.3 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Aduro BioTech
2.16.1 Business Overview
2.16.2 Aduro BioTech Immuno-oncology Drugs Product Introduction
2.16.3 Aduro BioTech Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Galena Biopharma
2.17.1 Business Overview
2.17.2 Galena Biopharma Immuno-oncology Drugs Product Introduction
2.17.3 Galena Biopharma Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Bavarian Nordic
2.18.1 Business Overview
2.18.2 Bavarian Nordic Immuno-oncology Drugs Product Introduction
2.18.3 Bavarian Nordic Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Celldex Therapeutics
2.19.1 Business Overview
2.19.2 Celldex Therapeutics Immuno-oncology Drugs Product Introduction
2.19.3 Celldex Therapeutics Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 ImmunoCellular Therapeutics
2.20.1 Business Overview
2.20.2 ImmunoCellular Therapeutics Immuno-oncology Drugs Product Introduction
2.20.3 ImmunoCellular Therapeutics Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21 Incyte
2.21.1 Business Overview
2.21.2 Incyte Immuno-oncology Drugs Product Introduction
2.21.3 Incyte Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL IMMUNO-ONCOLOGY DRUGS MARKET COMPETITION, BY MANUFACTURER
3.1 Global Immuno-oncology Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Immuno-oncology Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Immuno-oncology Drugs Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Immuno-oncology Drugs Manufacturer Market Share in 2017
3.4.2 Top 5 Immuno-oncology Drugs Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 GLOBAL IMMUNO-ONCOLOGY DRUGS MARKET ANALYSIS BY REGIONS
4.1 Global Immuno-oncology Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Immuno-oncology Drugs Sales by Regions (2013-2018)
4.1.2 Global Immuno-oncology Drugs Revenue by Regions (2013-2018)
4.2 North America Immuno-oncology Drugs Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Immuno-oncology Drugs Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Immuno-oncology Drugs Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Immuno-oncology Drugs Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Immuno-oncology Drugs Sales, Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA IMMUNO-ONCOLOGY DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
5.1 North America Immuno-oncology Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Immuno-oncology Drugs Sales by Countries (2013-2018)
5.1.2 North America Immuno-oncology Drugs Revenue by Countries (2013-2018)
5.1.3 United States Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
5.1.4 Canada Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
5.1.5 Mexico Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
5.2 North America Immuno-oncology Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Immuno-oncology Drugs Sales by Manufacturers (2016-2017)
5.2.2 North America Immuno-oncology Drugs Revenue by Manufacturers (2016-2017)
5.3 North America Immuno-oncology Drugs Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Immuno-oncology Drugs Sales and Sales Share by Type (2013-2018)
5.3.2 North America Immuno-oncology Drugs Revenue and Revenue Share by Type (2013-2018)
5.4 North America Immuno-oncology Drugs Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Immuno-oncology Drugs Sales and Sales Share by Application (2013-2018)
5.4.2 North America Immuno-oncology Drugs Revenue and Revenue Share by Application (2013-2018)
6 EUROPE IMMUNO-ONCOLOGY DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
6.1 Europe Immuno-oncology Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Immuno-oncology Drugs Sales by Countries (2013-2018)
6.1.2 Europe Immuno-oncology Drugs Revenue by Countries (2013-2018)
6.1.3 Germany Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
6.1.4 UK Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
6.1.5 France Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
6.1.6 Russia Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
6.1.7 Italy Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
6.2 Europe Immuno-oncology Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Immuno-oncology Drugs Sales by Manufacturers (2016-2017)
6.2.2 Europe Immuno-oncology Drugs Revenue by Manufacturers (2016-2017)
6.3 Europe Immuno-oncology Drugs Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Immuno-oncology Drugs Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Immuno-oncology Drugs Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Immuno-oncology Drugs Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Immuno-oncology Drugs Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Immuno-oncology Drugs Revenue and Revenue Share by Application (2013-2018)
7 ASIA-PACIFIC IMMUNO-ONCOLOGY DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
7.1 Asia-Pacific Immuno-oncology Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Immuno-oncology Drugs Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Immuno-oncology Drugs Revenue by Countries (2013-2018)
7.1.3 China Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
7.1.4 Japan Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
7.1.5 Korea Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
7.1.6 India Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Immuno-oncology Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Immuno-oncology Drugs Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Immuno-oncology Drugs Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Immuno-oncology Drugs Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Immuno-oncology Drugs Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Immuno-oncology Drugs Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Immuno-oncology Drugs Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Immuno-oncology Drugs Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Immuno-oncology Drugs Revenue and Revenue Share by Application (2013-2018)
8 SOUTH AMERICA IMMUNO-ONCOLOGY DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
8.1 South America Immuno-oncology Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Immuno-oncology Drugs Sales by Countries (2013-2018)
8.1.2 South America Immuno-oncology Drugs Revenue by Countries (2013-2018)
8.1.3 Brazil Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
8.1.4 Argentina Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
8.1.5 Colombia Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
8.2 South America Immuno-oncology Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Immuno-oncology Drugs Sales by Manufacturers (2016-2017)
8.2.2 South America Immuno-oncology Drugs Revenue by Manufacturers (2016-2017)
8.3 South America Immuno-oncology Drugs Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Immuno-oncology Drugs Sales and Sales Share by Type (2013-2018)
8.3.2 South America Immuno-oncology Drugs Revenue and Revenue Share by Type (2013-2018)
8.4 South America Immuno-oncology Drugs Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Immuno-oncology Drugs Sales and Sales Share by Application (2013-2018)
8.4.2 South America Immuno-oncology Drugs Revenue and Revenue Share by Application (2013-2018)
9 MIDDLE EAST AND AFRICA IMMUNO-ONCOLOGY DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
9.1 Middle East and Africa Immuno-oncology Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Immuno-oncology Drugs Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Immuno-oncology Drugs Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
9.1.4 UAE Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
9.1.5 Egypt Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
9.1.7 South Africa Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Immuno-oncology Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Immuno-oncology Drugs Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Immuno-oncology Drugs Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Immuno-oncology Drugs Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Immuno-oncology Drugs Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Immuno-oncology Drugs Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Immuno-oncology Drugs Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Immuno-oncology Drugs Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Immuno-oncology Drugs Revenue and Revenue Share by Application (2013-2018)
10 GLOBAL IMMUNO-ONCOLOGY DRUGS MARKET SEGMENT BY TYPE
10.1 Global Immuno-oncology Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Immuno-oncology Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Immuno-oncology Drugs Revenue and Market Share by Type (2013-2018)
10.2 Immune Checkpoint Inhibitors Sales Growth and Price
10.2.1 Global Immune Checkpoint Inhibitors Sales Growth (2013-2018)
10.2.2 Global Immune Checkpoint Inhibitors Price (2013-2018)
10.3 Monoclonal Antibodies Sales Growth and Price
10.3.1 Global Monoclonal Antibodies Sales Growth (2013-2018)
10.3.2 Global Monoclonal Antibodies Price (2013-2018)
10.4 Cytokine-Based Immunotherapy Sales Growth and Price
10.4.1 Global Cytokine-Based Immunotherapy Sales Growth (2013-2018)
10.4.2 Global Cytokine-Based Immunotherapy Price (2013-2018)
10.5 Cancer Vaccines Sales Growth and Price
10.5.1 Global Cancer Vaccines Sales Growth (2013-2018)
10.5.2 Global Cancer Vaccines Price (2013-2018)
10.6 CAR-T Cell Therapy Sales Growth and Price
10.6.1 Global CAR-T Cell Therapy Sales Growth (2013-2018)
10.6.2 Global CAR-T Cell Therapy Price (2013-2018)
11 GLOBAL IMMUNO-ONCOLOGY DRUGS MARKET SEGMENT BY APPLICATION
11.1 Global Immuno-oncology Drugs Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Pharmacies Sales Growth (2013-2018)
11.4 Online Pharmacies Sales Growth (2013-2018)
12 IMMUNO-ONCOLOGY DRUGS MARKET FORECAST (2018-2023)
12.1 Global Immuno-oncology Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Immuno-oncology Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Immuno-oncology Drugs Market Forecast (2018-2023)
12.2.2 Europe Immuno-oncology Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Immuno-oncology Drugs Market Forecast (2018-2023)
12.2.4 South America Immuno-oncology Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Immuno-oncology Drugs Market Forecast (2018-2023)
12.3 Immuno-oncology Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Immuno-oncology Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Immuno-oncology Drugs Market Share Forecast by Type (2018-2023)
12.4 Immuno-oncology Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Immuno-oncology Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Immuno-oncology Drugs Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
LIST OF TABLES AND FIGURES
Figure Immuno-oncology Drugs Picture
Table Product Specifications of Immuno-oncology Drugs
Figure Global Immuno-oncology Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Immuno-oncology Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Immuno-oncology Drugs by Types in 2017
Figure Immune Checkpoint Inhibitors Picture
Table Major Manufacturers of Immune Checkpoint Inhibitors
Figure Monoclonal Antibodies Picture
Table Major Manufacturers of Monoclonal Antibodies
Figure Cytokine-Based Immunotherapy Picture
Table Major Manufacturers of Cytokine-Based Immunotherapy
Figure Cancer Vaccines Picture
Table Major Manufacturers of Cancer Vaccines
Figure CAR-T Cell Therapy Picture
Table Major Manufacturers of CAR-T Cell Therapy
Figure Immuno-oncology Drugs Sales Market Share by Applications in 2017
Figure Hospitals Picture
Figure Pharmacies Picture
Figure Online Pharmacies Picture
Figure United States Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure France Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure UK Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure China Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure India Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Table Amgen, Inc Headquarter, Established, Main Business and Finance Overview (2017)
Table Amgen, Inc Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
Table Amgen, Inc Immuno-oncology Drugs Product
Table Amgen, Inc Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Amgen, Inc Immuno-oncology Drugs Sales Market Share in 2017
Figure Global Amgen, Inc Immuno-oncology Drugs Revenue Market Share in 2017
Table AstraZeneca, Plc Headquarter, Established, Main Business and Finance Overview (2017)
Table AstraZeneca, Plc Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
Table AstraZeneca, Plc Immuno-oncology Drugs Product
Table AstraZeneca, Plc Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AstraZeneca, Plc Immuno-oncology Drugs Sales Market Share in 2017
Figure Global AstraZeneca, Plc Immuno-oncology Drugs Revenue Market Share in 2017
Table Bristol-Myers Squibb Headquarter, Established, Main Business and Finance Overview (2017)
Table Bristol-Myers Squibb Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
Table Bristol-Myers Squibb Immuno-oncology Drugs Product
Table Bristol-Myers Squibb Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Bristol-Myers Squibb Immuno-oncology Drugs Sales Market Share in 2017
Figure Global Bristol-Myers Squibb Immuno-oncology Drugs Revenue Market Share in 2017
Table Celgene Corporation Headquarter, Established, Main Business and Finance Overview (2017)
Table Celgene Corporation Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
Table Celgene Corporation Immuno-oncology Drugs Product
Table Celgene Corporation Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Celgene Corporation Immuno-oncology Drugs Sales Market Share in 2017
Figure Global Celgene Corporation Immuno-oncology Drugs Revenue Market Share in 2017
Table Eli Lilly and Company Headquarter, Established, Main Business and Finance Overview (2017)
Table Eli Lilly and Company Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
Table Eli Lilly and Company Immuno-oncology Drugs Product
Table Eli Lilly and Company Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Eli Lilly and Company Immuno-oncology Drugs Sales Market Share in 2017
Figure Global Eli Lilly and Company Immuno-oncology Drugs Revenue Market Share in 2017
Table Merck & Co. Headquarter, Established, Main Business and Finance Overview (2017)
Table Merck & Co. Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
Table Merck & Co. Immuno-oncology Drugs Product
Table Merck & Co. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Merck & Co. Immuno-oncology Drugs Sales Market Share in 2017
Figure Global Merck & Co. Immuno-oncology Drugs Revenue Market Share in 2017
Table Hoffmann-La Roche AG Headquarter, Established, Main Business and Finance Overview (2017)
Table Hoffmann-La Roche AG Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
Table Hoffmann-La Roche AG Immuno-oncology Drugs Product
Table Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Hoffmann-La Roche AG Immuno-oncology Drugs Sales Market Share in 2017
Figure Global Hoffmann-La Roche AG Immuno-oncology Drugs Revenue Market Share in 2017
Table Johnson & Johnson Headquarter, Established, Main Business and Finance Overview (2017)
Table Johnson & Johnson Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
Table Johnson & Johnson Immuno-oncology Drugs Product
Table Johnson & Johnson Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Johnson & Johnson Immuno-oncology Drugs Sales Market Share in 2017
Figure Global Johnson & Johnson Immuno-oncology Drugs Revenue Market Share in 2017
Table Novartis International AG Headquarter, Established, Main Business and Finance Overview (2017)
Table Novartis International AG Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
Table Novartis International AG Immuno-oncology Drugs Product
Table Novartis International AG Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novartis International AG Immuno-oncology Drugs Sales Market Share in 2017
Figure Global Novartis International AG Immuno-oncology Drugs Revenue Market Share in 2017
Table AbbVie, Inc. Headquarter, Established, Main Business and Finance Overview (2017)
Table AbbVie, Inc. Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
Table AbbVie, Inc. Immuno-oncology Drugs Product
Table AbbVie, Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AbbVie, Inc. Immuno-oncology Drugs Sales Market Share in 2017
Figure Global AbbVie, Inc. Immuno-oncology Drugs Revenue Market Share in 2017
Table Pfizer Inc.
Table Pfizer Inc. Immuno-oncology Drugs
Table Sanofi S.A.
Table Sanofi S.A. Immuno-oncology Drugs
Table EMD Serono, Inc.
Table EMD Serono, Inc. Immuno-oncology Drugs
Table Gilead Sciences Inc.
Table Gilead Sciences Inc. Immuno-oncology Drugs
Table Prometheus Therapeutics & Diagnostics
Table Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs
Table Aduro BioTech
Table Aduro BioTech Immuno-oncology Drugs
Table Galena Biopharma
Table Galena Biopharma Immuno-oncology Drugs
Table Bavarian Nordic
Table Bavarian Nordic Immuno-oncology Drugs
Table Celldex Therapeutics
Table Celldex Therapeutics Immuno-oncology Drugs
Table ImmunoCellular Therapeutics
Table ImmunoCellular Therapeutics Immuno-oncology Drugs
Table Incyte
Table Incyte Immuno-oncology Drugs
Table Global Immuno-oncology Drugs Sales by Manufacturer (2016-2017)
Figure Global Immuno-oncology Drugs Sales Market Share by Manufacturer in 2016
Figure Global Immuno-oncology Drugs Sales Market Share by Manufacturer in 2017
Table Global Immuno-oncology Drugs Revenue by Manufacturer (2016-2017)
Figure Global Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2017
Table Global Immuno-oncology Drugs Price by Manufacturer (2016-2017)
Figure Top 3 Immuno-oncology Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Immuno-oncology Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure Global Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
Table Global Immuno-oncology Drugs Sales by Regions (2013-2018)
Table Global Immuno-oncology Drugs Sales Market Share by Regions (2013-2018)
Table Global Immuno-oncology Drugs Revenue by Regions (2013-2018)
Figure Global Immuno-oncology Drugs Revenue Market Share by Regions in 2013
Figure Global Immuno-oncology Drugs Revenue Market Share by Regions in 2017
Figure North America Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure North America Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
Figure Europe Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure Europe Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
Figure South America Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure South America Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
Figure North America Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
Table North America Immuno-oncology Drugs Sales by Countries (2013-2018)
Table North America Immuno-oncology Drugs Sales Market Share by Countries (2013-2018)
Figure North America Immuno-oncology Drugs Sales Market Share by Countries in 2013
Figure North America Immuno-oncology Drugs Sales Market Share by Countries in 2017
Table North America Immuno-oncology Drugs Revenue by Countries (2013-2018)
Table North America Immuno-oncology Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Immuno-oncology Drugs Revenue Market Share by Countries in 2013
Figure North America Immuno-oncology Drugs Revenue Market Share by Countries in 2017
Figure United States Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure Canada Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure Mexico Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Table North America Immuno-oncology Drugs Sales by Manufacturer (2016-2017)
Figure North America Immuno-oncology Drugs Sales Market Share by Manufacturer in 2016
Figure North America Immuno-oncology Drugs Sales Market Share by Manufacturer in 2017
Table North America Immuno-oncology Drugs Revenue by Manufacturer (2016-2017)
Figure North America Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2016
Figure North America Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2017
Table North America Immuno-oncology Drugs Sales by Type (2013-2018)
Table North America Immuno-oncology Drugs Sales Share by Type (2013-2018)
Table North America Immuno-oncology Drugs Revenue by Type (2013-2018)
Table North America Immuno-oncology Drugs Revenue Share by Type (2013-2018)
Table North America Immuno-oncology Drugs Sales by Application (2013-2018)
Table North America Immuno-oncology Drugs Sales Share by Application (2013-2018)
Table North America Immuno-oncology Drugs Revenue by Application (2013-2018)
Table North America Immuno-oncology Drugs Revenue Share by Application (2013-2018)
Figure Europe Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
Table Europe Immuno-oncology Drugs Sales by Countries (2013-2018)
Table Europe Immuno-oncology Drugs Sales Market Share by Countries (2013-2018)
Table Europe Immuno-oncology Drugs Revenue by Countries (2013-2018)
Figure Europe Immuno-oncology Drugs Revenue Market Share by Countries in 2016
Figure Europe Immuno-oncology Drugs Revenue Market Share by Countries in 2017
Figure Germany Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure UK Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure France Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure Russia Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure Italy Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Table Europe Immuno-oncology Drugs Sales by Manufacturer (2016-2017)
Figure Europe Immuno-oncology Drugs Sales Market Share by Manufacturer in 2016
Figure Europe Immuno-oncology Drugs Sales Market Share by Manufacturer in 2017
Table Europe Immuno-oncology Drugs Revenue by Manufacturer (2016-2017)
Figure Europe Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2016
Figure Europe Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2017
Table Europe Immuno-oncology Drugs Sales by Type (2013-2018)
Table Europe Immuno-oncology Drugs Sales Share by Type (2013-2018)
Table Europe Immuno-oncology Drugs Revenue by Type (2013-2018)
Table Europe Immuno-oncology Drugs Revenue Share by Type (2013-2018)
Table Europe Immuno-oncology Drugs Sales by Application (2013-2018)
Table Europe Immuno-oncology Drugs Sales Share by Application (2013-2018)
Table Europe Immuno-oncology Drugs Revenue by Application (2013-2018)
Table Europe Immuno-oncology Drugs Revenue Share by Application (2013-2018)
Figure Asia-Pacific Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Immuno-oncology Drugs Sales by Countries (2013-2018)
Table Asia-Pacific Immuno-oncology Drugs Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Immuno-oncology Drugs Sales Market Share by Countries 2017
Table Asia-Pacific Immuno-oncology Drugs Revenue by Countries (2013-2018)
Figure Asia-Pacific Immuno-oncology Drugs Revenue Market Share by Countries 2017
Figure China Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure Japan Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure Korea Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure India Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure Southeast Asia Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Table Asia-Pacific Immuno-oncology Drugs Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Immuno-oncology Drugs Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Immuno-oncology Drugs Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Immuno-oncology Drugs Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Immuno-oncology Drugs Sales by Type (2013-2018)
Table Asia-Pacific Immuno-oncology Drugs Sales Share by Type (2013-2018)
Table Asia-Pacific Immuno-oncology Drugs Revenue by Type (2013-2018)
Table Asia-Pacific Immuno-oncology Drugs Revenue Share by Type (2013-2018)
Table Asia-Pacific Immuno-oncology Drugs Sales by Application (2013-2018)
Table Asia-Pacific Immuno-oncology Drugs Sales Share by Application (2013-2018)
Table Asia-Pacific Immuno-oncology Drugs Revenue by Application (2013-2018)
Table Asia-Pacific Immuno-oncology Drugs Revenue Share by Application (2013-2018)
Figure South America Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
Table South America Immuno-oncology Drugs Sales by Countries (2013-2018)
Table South America Immuno-oncology Drugs Sales Market Share by Countries (2013-2018)
Figure South America Immuno-oncology Drugs Sales Market Share by Countries in 2017
Table South America Immuno-oncology Drugs Revenue by Countries (2013-2018)
Table South America Immuno-oncology Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Immuno-oncology Drugs Revenue Market Share by Countries in 2017
Figure Brazil Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure Argentina Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure Colombia Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Table South America Immuno-oncology Drugs Sales by Manufacturer (2016-2017)
Figure South America Immuno-oncology Drugs Sales Market Share by Manufacturer in 2016
Figure South America Immuno-oncology Drugs Sales Market Share by Manufacturer in 2017
Table South America Immuno-oncology Drugs Revenue by Manufacturer (2016-2017)
Figure South America Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2016
Figure South America Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2017
Table South America Immuno-oncology Drugs Sales by Type (2013-2018)
Table South America Immuno-oncology Drugs Sales Share by Type (2013-2018)
Table South America Immuno-oncology Drugs Revenue by Type (2013-2018)
Table South America Immuno-oncology Drugs Revenue Share by Type (2013-2018)
Table South America Immuno-oncology Drugs Sales by Application (2013-2018)
Table South America Immuno-oncology Drugs Sales Share by Application (2013-2018)
Table South America Immuno-oncology Drugs Revenue by Application (2013-2018)
Table South America Immuno-oncology Drugs Revenue Share by Application (2013-2018)
Figure Middle East and Africa Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Immuno-oncology Drugs Sales by Countries (2013-2018)
Table Middle East and Africa Immuno-oncology Drugs Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Immuno-oncology Drugs Sales Market Share by Countries in 2017
Table Middle East and Africa Immuno-oncology Drugs Revenue by Countries (2013-2018)
Table Middle East and Africa Immuno-oncology Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Immuno-oncology Drugs Revenue Market Share by Countries in 2013
Figure Middle East and Africa Immuno-oncology Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure UAE Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure Egypt Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure Nigeria Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure South Africa Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Table Middle East and Africa Immuno-oncology Drugs Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Immuno-oncology Drugs Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Immuno-oncology Drugs Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Immuno-oncology Drugs Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Immuno-oncology Drugs Sales by Type (2013-2018)
Table Middle East and Africa Immuno-oncology Drugs Sales Share by Type (2013-2018)
Table Middle East and Africa Immuno-oncology Drugs Revenue by Type (2013-2018)
Table Middle East and Africa Immuno-oncology Drugs Revenue Share by Type (2013-2018)
Table Middle East and Africa Immuno-oncology Drugs Sales by Application (2013-2018)
Table Middle East and Africa Immuno-oncology Drugs Sales Share by Application (2013-2018)
Table Middle East and Africa Immuno-oncology Drugs Revenue by Application (2013-2018)
Table Middle East and Africa Immuno-oncology Drugs Revenue Share by Application (2013-2018)
Table Global Immuno-oncology Drugs Sales by Type (2013-2018)
Table Global Immuno-oncology Drugs Sales Share by Type (2013-2018)
Table Global Immuno-oncology Drugs Revenue by Type (2013-2018)
Table Global Immuno-oncology Drugs Revenue Share by Type (2013-2018)
Figure Global Immune Checkpoint Inhibitors Sales Growth (2013-2018)
Figure Global Immune Checkpoint Inhibitors Price (2013-2018)
Figure Global Monoclonal Antibodies Sales Growth (2013-2018)
Figure Global Monoclonal Antibodies Price (2013-2018)
Figure Global Cytokine-Based Immunotherapy Sales Growth (2013-2018)
Figure Global Cytokine-Based Immunotherapy Price (2013-2018)
Figure Global Cancer Vaccines Sales Growth (2013-2018)
Figure Global Cancer Vaccines Price (2013-2018)
Figure Global CAR-T Cell Therapy Sales Growth (2013-2018)
Figure Global CAR-T Cell Therapy Price (2013-2018)
Table Global Immuno-oncology Drugs Sales by Application (2013-2018)
Table Global Immuno-oncology Drugs Sales Share by Application (2013-2018)
Figure Global Hospitals Sales Growth (2013-2018)
Figure Global Pharmacies Sales Growth (2013-2018)
Figure Global Online Pharmacies Sales Growth (2013-2018)
Figure Global Immuno-oncology Drugs Sales, Revenue and Growth Rate (2018-2023)
Table Global Immuno-oncology Drugs Sales Forecast by Regions (2018-2023)
Table Global Immuno-oncology Drugs Market Share Forecast by Regions (2018-2023)
Figure North America Sales Immuno-oncology Drugs Market Forecast (2018-2023)
Figure Europe Sales Immuno-oncology Drugs Market Forecast (2018-2023)
Figure Asia-Pacific Sales Immuno-oncology Drugs Market Forecast (2018-2023)
Figure South America Sales Immuno-oncology Drugs Market Forecast (2018-2023)
Figure Middle East and Africa Sales Immuno-oncology Drugs Market Forecast (2018-2023)
Table Global Immuno-oncology Drugs Sales Forecast by Type (2018-2023)
Table Global Immuno-oncology Drugs Market Share Forecast by Type (2018-2023)
Table Global Immuno-oncology Drugs Sales Forecast by Application (2018-2023)
Table Global Immuno-oncology Drugs Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
Figure Immuno-oncology Drugs Picture
Table Product Specifications of Immuno-oncology Drugs
Figure Global Immuno-oncology Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Immuno-oncology Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Immuno-oncology Drugs by Types in 2017
Figure Immune Checkpoint Inhibitors Picture
Table Major Manufacturers of Immune Checkpoint Inhibitors
Figure Monoclonal Antibodies Picture
Table Major Manufacturers of Monoclonal Antibodies
Figure Cytokine-Based Immunotherapy Picture
Table Major Manufacturers of Cytokine-Based Immunotherapy
Figure Cancer Vaccines Picture
Table Major Manufacturers of Cancer Vaccines
Figure CAR-T Cell Therapy Picture
Table Major Manufacturers of CAR-T Cell Therapy
Figure Immuno-oncology Drugs Sales Market Share by Applications in 2017
Figure Hospitals Picture
Figure Pharmacies Picture
Figure Online Pharmacies Picture
Figure United States Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure France Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure UK Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure China Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure India Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023)
Table Amgen, Inc Headquarter, Established, Main Business and Finance Overview (2017)
Table Amgen, Inc Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
Table Amgen, Inc Immuno-oncology Drugs Product
Table Amgen, Inc Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Amgen, Inc Immuno-oncology Drugs Sales Market Share in 2017
Figure Global Amgen, Inc Immuno-oncology Drugs Revenue Market Share in 2017
Table AstraZeneca, Plc Headquarter, Established, Main Business and Finance Overview (2017)
Table AstraZeneca, Plc Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
Table AstraZeneca, Plc Immuno-oncology Drugs Product
Table AstraZeneca, Plc Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AstraZeneca, Plc Immuno-oncology Drugs Sales Market Share in 2017
Figure Global AstraZeneca, Plc Immuno-oncology Drugs Revenue Market Share in 2017
Table Bristol-Myers Squibb Headquarter, Established, Main Business and Finance Overview (2017)
Table Bristol-Myers Squibb Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
Table Bristol-Myers Squibb Immuno-oncology Drugs Product
Table Bristol-Myers Squibb Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Bristol-Myers Squibb Immuno-oncology Drugs Sales Market Share in 2017
Figure Global Bristol-Myers Squibb Immuno-oncology Drugs Revenue Market Share in 2017
Table Celgene Corporation Headquarter, Established, Main Business and Finance Overview (2017)
Table Celgene Corporation Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
Table Celgene Corporation Immuno-oncology Drugs Product
Table Celgene Corporation Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Celgene Corporation Immuno-oncology Drugs Sales Market Share in 2017
Figure Global Celgene Corporation Immuno-oncology Drugs Revenue Market Share in 2017
Table Eli Lilly and Company Headquarter, Established, Main Business and Finance Overview (2017)
Table Eli Lilly and Company Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
Table Eli Lilly and Company Immuno-oncology Drugs Product
Table Eli Lilly and Company Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Eli Lilly and Company Immuno-oncology Drugs Sales Market Share in 2017
Figure Global Eli Lilly and Company Immuno-oncology Drugs Revenue Market Share in 2017
Table Merck & Co. Headquarter, Established, Main Business and Finance Overview (2017)
Table Merck & Co. Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
Table Merck & Co. Immuno-oncology Drugs Product
Table Merck & Co. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Merck & Co. Immuno-oncology Drugs Sales Market Share in 2017
Figure Global Merck & Co. Immuno-oncology Drugs Revenue Market Share in 2017
Table Hoffmann-La Roche AG Headquarter, Established, Main Business and Finance Overview (2017)
Table Hoffmann-La Roche AG Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
Table Hoffmann-La Roche AG Immuno-oncology Drugs Product
Table Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Hoffmann-La Roche AG Immuno-oncology Drugs Sales Market Share in 2017
Figure Global Hoffmann-La Roche AG Immuno-oncology Drugs Revenue Market Share in 2017
Table Johnson & Johnson Headquarter, Established, Main Business and Finance Overview (2017)
Table Johnson & Johnson Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
Table Johnson & Johnson Immuno-oncology Drugs Product
Table Johnson & Johnson Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Johnson & Johnson Immuno-oncology Drugs Sales Market Share in 2017
Figure Global Johnson & Johnson Immuno-oncology Drugs Revenue Market Share in 2017
Table Novartis International AG Headquarter, Established, Main Business and Finance Overview (2017)
Table Novartis International AG Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
Table Novartis International AG Immuno-oncology Drugs Product
Table Novartis International AG Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novartis International AG Immuno-oncology Drugs Sales Market Share in 2017
Figure Global Novartis International AG Immuno-oncology Drugs Revenue Market Share in 2017
Table AbbVie, Inc. Headquarter, Established, Main Business and Finance Overview (2017)
Table AbbVie, Inc. Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors
Table AbbVie, Inc. Immuno-oncology Drugs Product
Table AbbVie, Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AbbVie, Inc. Immuno-oncology Drugs Sales Market Share in 2017
Figure Global AbbVie, Inc. Immuno-oncology Drugs Revenue Market Share in 2017
Table Pfizer Inc.
Table Pfizer Inc. Immuno-oncology Drugs
Table Sanofi S.A.
Table Sanofi S.A. Immuno-oncology Drugs
Table EMD Serono, Inc.
Table EMD Serono, Inc. Immuno-oncology Drugs
Table Gilead Sciences Inc.
Table Gilead Sciences Inc. Immuno-oncology Drugs
Table Prometheus Therapeutics & Diagnostics
Table Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs
Table Aduro BioTech
Table Aduro BioTech Immuno-oncology Drugs
Table Galena Biopharma
Table Galena Biopharma Immuno-oncology Drugs
Table Bavarian Nordic
Table Bavarian Nordic Immuno-oncology Drugs
Table Celldex Therapeutics
Table Celldex Therapeutics Immuno-oncology Drugs
Table ImmunoCellular Therapeutics
Table ImmunoCellular Therapeutics Immuno-oncology Drugs
Table Incyte
Table Incyte Immuno-oncology Drugs
Table Global Immuno-oncology Drugs Sales by Manufacturer (2016-2017)
Figure Global Immuno-oncology Drugs Sales Market Share by Manufacturer in 2016
Figure Global Immuno-oncology Drugs Sales Market Share by Manufacturer in 2017
Table Global Immuno-oncology Drugs Revenue by Manufacturer (2016-2017)
Figure Global Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2017
Table Global Immuno-oncology Drugs Price by Manufacturer (2016-2017)
Figure Top 3 Immuno-oncology Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Immuno-oncology Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure Global Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
Table Global Immuno-oncology Drugs Sales by Regions (2013-2018)
Table Global Immuno-oncology Drugs Sales Market Share by Regions (2013-2018)
Table Global Immuno-oncology Drugs Revenue by Regions (2013-2018)
Figure Global Immuno-oncology Drugs Revenue Market Share by Regions in 2013
Figure Global Immuno-oncology Drugs Revenue Market Share by Regions in 2017
Figure North America Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure North America Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
Figure Europe Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure Europe Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
Figure South America Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure South America Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
Figure North America Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
Table North America Immuno-oncology Drugs Sales by Countries (2013-2018)
Table North America Immuno-oncology Drugs Sales Market Share by Countries (2013-2018)
Figure North America Immuno-oncology Drugs Sales Market Share by Countries in 2013
Figure North America Immuno-oncology Drugs Sales Market Share by Countries in 2017
Table North America Immuno-oncology Drugs Revenue by Countries (2013-2018)
Table North America Immuno-oncology Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Immuno-oncology Drugs Revenue Market Share by Countries in 2013
Figure North America Immuno-oncology Drugs Revenue Market Share by Countries in 2017
Figure United States Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure Canada Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure Mexico Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Table North America Immuno-oncology Drugs Sales by Manufacturer (2016-2017)
Figure North America Immuno-oncology Drugs Sales Market Share by Manufacturer in 2016
Figure North America Immuno-oncology Drugs Sales Market Share by Manufacturer in 2017
Table North America Immuno-oncology Drugs Revenue by Manufacturer (2016-2017)
Figure North America Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2016
Figure North America Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2017
Table North America Immuno-oncology Drugs Sales by Type (2013-2018)
Table North America Immuno-oncology Drugs Sales Share by Type (2013-2018)
Table North America Immuno-oncology Drugs Revenue by Type (2013-2018)
Table North America Immuno-oncology Drugs Revenue Share by Type (2013-2018)
Table North America Immuno-oncology Drugs Sales by Application (2013-2018)
Table North America Immuno-oncology Drugs Sales Share by Application (2013-2018)
Table North America Immuno-oncology Drugs Revenue by Application (2013-2018)
Table North America Immuno-oncology Drugs Revenue Share by Application (2013-2018)
Figure Europe Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
Table Europe Immuno-oncology Drugs Sales by Countries (2013-2018)
Table Europe Immuno-oncology Drugs Sales Market Share by Countries (2013-2018)
Table Europe Immuno-oncology Drugs Revenue by Countries (2013-2018)
Figure Europe Immuno-oncology Drugs Revenue Market Share by Countries in 2016
Figure Europe Immuno-oncology Drugs Revenue Market Share by Countries in 2017
Figure Germany Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure UK Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure France Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure Russia Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure Italy Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Table Europe Immuno-oncology Drugs Sales by Manufacturer (2016-2017)
Figure Europe Immuno-oncology Drugs Sales Market Share by Manufacturer in 2016
Figure Europe Immuno-oncology Drugs Sales Market Share by Manufacturer in 2017
Table Europe Immuno-oncology Drugs Revenue by Manufacturer (2016-2017)
Figure Europe Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2016
Figure Europe Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2017
Table Europe Immuno-oncology Drugs Sales by Type (2013-2018)
Table Europe Immuno-oncology Drugs Sales Share by Type (2013-2018)
Table Europe Immuno-oncology Drugs Revenue by Type (2013-2018)
Table Europe Immuno-oncology Drugs Revenue Share by Type (2013-2018)
Table Europe Immuno-oncology Drugs Sales by Application (2013-2018)
Table Europe Immuno-oncology Drugs Sales Share by Application (2013-2018)
Table Europe Immuno-oncology Drugs Revenue by Application (2013-2018)
Table Europe Immuno-oncology Drugs Revenue Share by Application (2013-2018)
Figure Asia-Pacific Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Immuno-oncology Drugs Sales by Countries (2013-2018)
Table Asia-Pacific Immuno-oncology Drugs Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Immuno-oncology Drugs Sales Market Share by Countries 2017
Table Asia-Pacific Immuno-oncology Drugs Revenue by Countries (2013-2018)
Figure Asia-Pacific Immuno-oncology Drugs Revenue Market Share by Countries 2017
Figure China Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure Japan Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure Korea Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure India Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure Southeast Asia Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Table Asia-Pacific Immuno-oncology Drugs Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Immuno-oncology Drugs Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Immuno-oncology Drugs Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Immuno-oncology Drugs Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Immuno-oncology Drugs Sales by Type (2013-2018)
Table Asia-Pacific Immuno-oncology Drugs Sales Share by Type (2013-2018)
Table Asia-Pacific Immuno-oncology Drugs Revenue by Type (2013-2018)
Table Asia-Pacific Immuno-oncology Drugs Revenue Share by Type (2013-2018)
Table Asia-Pacific Immuno-oncology Drugs Sales by Application (2013-2018)
Table Asia-Pacific Immuno-oncology Drugs Sales Share by Application (2013-2018)
Table Asia-Pacific Immuno-oncology Drugs Revenue by Application (2013-2018)
Table Asia-Pacific Immuno-oncology Drugs Revenue Share by Application (2013-2018)
Figure South America Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
Table South America Immuno-oncology Drugs Sales by Countries (2013-2018)
Table South America Immuno-oncology Drugs Sales Market Share by Countries (2013-2018)
Figure South America Immuno-oncology Drugs Sales Market Share by Countries in 2017
Table South America Immuno-oncology Drugs Revenue by Countries (2013-2018)
Table South America Immuno-oncology Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Immuno-oncology Drugs Revenue Market Share by Countries in 2017
Figure Brazil Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure Argentina Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure Colombia Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Table South America Immuno-oncology Drugs Sales by Manufacturer (2016-2017)
Figure South America Immuno-oncology Drugs Sales Market Share by Manufacturer in 2016
Figure South America Immuno-oncology Drugs Sales Market Share by Manufacturer in 2017
Table South America Immuno-oncology Drugs Revenue by Manufacturer (2016-2017)
Figure South America Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2016
Figure South America Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2017
Table South America Immuno-oncology Drugs Sales by Type (2013-2018)
Table South America Immuno-oncology Drugs Sales Share by Type (2013-2018)
Table South America Immuno-oncology Drugs Revenue by Type (2013-2018)
Table South America Immuno-oncology Drugs Revenue Share by Type (2013-2018)
Table South America Immuno-oncology Drugs Sales by Application (2013-2018)
Table South America Immuno-oncology Drugs Sales Share by Application (2013-2018)
Table South America Immuno-oncology Drugs Revenue by Application (2013-2018)
Table South America Immuno-oncology Drugs Revenue Share by Application (2013-2018)
Figure Middle East and Africa Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Immuno-oncology Drugs Sales by Countries (2013-2018)
Table Middle East and Africa Immuno-oncology Drugs Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Immuno-oncology Drugs Sales Market Share by Countries in 2017
Table Middle East and Africa Immuno-oncology Drugs Revenue by Countries (2013-2018)
Table Middle East and Africa Immuno-oncology Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Immuno-oncology Drugs Revenue Market Share by Countries in 2013
Figure Middle East and Africa Immuno-oncology Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure UAE Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure Egypt Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure Nigeria Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Figure South Africa Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
Table Middle East and Africa Immuno-oncology Drugs Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Immuno-oncology Drugs Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Immuno-oncology Drugs Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Immuno-oncology Drugs Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Immuno-oncology Drugs Sales by Type (2013-2018)
Table Middle East and Africa Immuno-oncology Drugs Sales Share by Type (2013-2018)
Table Middle East and Africa Immuno-oncology Drugs Revenue by Type (2013-2018)
Table Middle East and Africa Immuno-oncology Drugs Revenue Share by Type (2013-2018)
Table Middle East and Africa Immuno-oncology Drugs Sales by Application (2013-2018)
Table Middle East and Africa Immuno-oncology Drugs Sales Share by Application (2013-2018)
Table Middle East and Africa Immuno-oncology Drugs Revenue by Application (2013-2018)
Table Middle East and Africa Immuno-oncology Drugs Revenue Share by Application (2013-2018)
Table Global Immuno-oncology Drugs Sales by Type (2013-2018)
Table Global Immuno-oncology Drugs Sales Share by Type (2013-2018)
Table Global Immuno-oncology Drugs Revenue by Type (2013-2018)
Table Global Immuno-oncology Drugs Revenue Share by Type (2013-2018)
Figure Global Immune Checkpoint Inhibitors Sales Growth (2013-2018)
Figure Global Immune Checkpoint Inhibitors Price (2013-2018)
Figure Global Monoclonal Antibodies Sales Growth (2013-2018)
Figure Global Monoclonal Antibodies Price (2013-2018)
Figure Global Cytokine-Based Immunotherapy Sales Growth (2013-2018)
Figure Global Cytokine-Based Immunotherapy Price (2013-2018)
Figure Global Cancer Vaccines Sales Growth (2013-2018)
Figure Global Cancer Vaccines Price (2013-2018)
Figure Global CAR-T Cell Therapy Sales Growth (2013-2018)
Figure Global CAR-T Cell Therapy Price (2013-2018)
Table Global Immuno-oncology Drugs Sales by Application (2013-2018)
Table Global Immuno-oncology Drugs Sales Share by Application (2013-2018)
Figure Global Hospitals Sales Growth (2013-2018)
Figure Global Pharmacies Sales Growth (2013-2018)
Figure Global Online Pharmacies Sales Growth (2013-2018)
Figure Global Immuno-oncology Drugs Sales, Revenue and Growth Rate (2018-2023)
Table Global Immuno-oncology Drugs Sales Forecast by Regions (2018-2023)
Table Global Immuno-oncology Drugs Market Share Forecast by Regions (2018-2023)
Figure North America Sales Immuno-oncology Drugs Market Forecast (2018-2023)
Figure Europe Sales Immuno-oncology Drugs Market Forecast (2018-2023)
Figure Asia-Pacific Sales Immuno-oncology Drugs Market Forecast (2018-2023)
Figure South America Sales Immuno-oncology Drugs Market Forecast (2018-2023)
Figure Middle East and Africa Sales Immuno-oncology Drugs Market Forecast (2018-2023)
Table Global Immuno-oncology Drugs Sales Forecast by Type (2018-2023)
Table Global Immuno-oncology Drugs Market Share Forecast by Type (2018-2023)
Table Global Immuno-oncology Drugs Sales Forecast by Application (2018-2023)
Table Global Immuno-oncology Drugs Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
